SCHEMBL4859751

SCHEMBL4859751

CC(C)(O)C(O)CON1C(=O)c2ccccc2C1=O

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
GAA P10253 1/20 0.47
ALDH1A1 P00352 6/20 0.45
CYP1A2 P05177 3/20 0.45
CYP2C9 P11712 1/20 0.45
KMT2A Q03164 4/20 0.44
MEN1 O00255 2/20 0.44
HPGD P15428 1/20 0.44
ATM Q13315 1/20 0.44
MAPT P10636 2/20 0.42
RECQL P46063 1/20 0.41
HTT P42858 1/20 0.39
MAPK1 P28482 1/20 0.39
BLM P54132 1/20 0.39
CYP3A4 P08684 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3978571 0.89 POLB (0.55) POLBSMN1; SMN2GAAALDH1A1CYP1A2
SCHEMBL12767417 0.85 GAA (0.53) POLBSMN1; SMN2GAAALDH1A1CYP1A2
SCHEMBL2296722 0.80 POLB (0.58) POLBSMN1; SMN2GAAALDH1A1CYP1A2
SCHEMBL31208299 0.80 POLB (0.58) POLBSMN1; SMN2GAAALDH1A1CYP1A2
SCHEMBL2296725 0.80 POLB (0.58) POLBSMN1; SMN2GAAALDH1A1CYP1A2
SCHEMBL529416 0.80 POLB (0.70) POLBSMN1; SMN2GAAALDH1A1CYP1A2
SCHEMBL8752996 0.78 POLB (0.56) POLBSMN1; SMN2GAAALDH1A1CYP1A2
SCHEMBL30375313 0.77 GAA (0.53) POLBSMN1; SMN2GAAALDH1A1CYP1A2
SCHEMBL2570420 0.77 GAA (0.53) POLBSMN1; SMN2GAAALDH1A1CYP1A2
SCHEMBL3576904 0.76 GAA (0.56) POLBSMN1; SMN2GAAALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1301472-B1 OXYGENATED ESTERS OF 4-IODO PHENYLAMINO BENZHYDROXAMIC ACIDS WARNER LAMBERT CO (US) 2014-03-26 EP disclosed
US-7411001-B2 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids WARNER-LAMBERT COMPANY (US) 2008-08-12 US disclosed
US-6960614-B2 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids WARNER-LAMBERT COMPANY (US) 2005-11-01 US disclosed
US-20050176820-A1 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids WARNER-LAMBERT COMPANY 2005-08-11 US disclosed
US-20040054172-A1 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids WARNER-LAMBERT COMPANY 2004-03-18 US disclosed
EP-1301472-A2 OXYGENATED ESTERS OF 4-IODO PHENYLAMINO BENZHYDROXAMIC ACIDS WARNER-LAMBERT COMPANY (US) 2003-04-16 EP disclosed
WO-2002006213-A2 OXYGENATED ESTERS OF 4-IODO PHENYLAMINO BENZHYDROXAMIC ACIDS WARNER-LAMBERT COMPANY (US) 2002-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050176820-A1 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids CYP4X1, CYP2A7, CYP4B1 POLB 2002/4885SMN1; SMN2 4223/4885GAA 818/4885
US-20040054172-A1 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids CYP4X1, ALOX5, HAAO POLB 2272/4885SMN1; SMN2 4376/4885GAA 519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.